Combined SN-38 and gefitinib treatment promotes CD44 degradation in head and neck squamous cell carcinoma cells.
| Image |  |
|---|---|
| Description | scientific article published on 21 November 2017 |
| Author/s |
author: Naoki Umemura Hiroshi Sakagami |
| Publication date | November 21, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |